MERRILLVILLE | Purdue Technology Center-based Euclid Diagnostics, Inc., will receive a $287,000 grant through the Small Business Innovation Research program.
The grant, announced by U.S. Rep. Visclosky on Tuesday, will fund research into new methods to identify individuals who require biopsies for prostate cancer, according to a news release.
“The work being done at Euclid Diagnostics, LLC to develop a screening test for prostate cancer will benefit people around the world," said Purdue Technology Center of Northwest Indiana Director Kathy DeGuilio-Fox in a statement. "... All companies located in the park are improving people’s lives by developing processes and products in multiple sectors, including life sciences, energy, engineering, information technology and media.”
Visclosky also lauded the company and its research.
“Euclid Diagnostics receiving this highly competitive award represents a great moment for the company, Purdue Technology Center, and the community,” Visclosky said in a statement. “It proves that private-public partnerships can create jobs and increase opportunity in Northwest Indiana. This sort of groundbreaking, innovative research speaks to the vision and capability of Euclid Diagnostics, and the quality of support offered by the Purdue Technology Center.”
SBIR is a competitive grant program designed to assist small businesses with research and development on projects with prospects for commercialization.